Barbara Meissner

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.

LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.

Journal: Blood advances
Published: February 13, 2026

Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.

Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.

Journal: Blood advances
Published: May 28, 2025

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Journal: medRxiv : the preprint server for health sciences
Published: March 31, 2025

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Journal: Blood advances
Published: March 26, 2025

Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma.

Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma.

Journal: Blood
Published: January 16, 2025

CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL.

CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL.

Journal: Blood
Published: June 11, 2024

Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.

Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.

Journal: American journal of hematology
Published: June 10, 2024

Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2.

Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2.

Journal: Blood
Published: June 03, 2024

Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study).

Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study).

Journal: Blood
Published: February 09, 2024

Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.

Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 15, 2023

Relapse timing is associated with distinct evolutionary dynamics in DLBCL.

Relapse timing is associated with distinct evolutionary dynamics in DLBCL.

Journal: medRxiv : the preprint server for health sciences
Published: March 22, 2023

Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.

Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.

Journal: Clinical chemistry
Published: March 14, 2023
Showing 1-12 of 36

Last Updated: 09/26/2026